439 related articles for article (PubMed ID: 26240749)
1. Legal highs: staying on top of the flood of novel psychoactive substances.
Baumeister D; Tojo LM; Tracy DK
Ther Adv Psychopharmacol; 2015 Apr; 5(2):97-132. PubMed ID: 26240749
[TBL] [Abstract][Full Text] [Related]
2. "Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances.
Zawilska JB
Int Rev Neurobiol; 2015; 120():273-300. PubMed ID: 26070762
[TBL] [Abstract][Full Text] [Related]
3. What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties.
Rychert M; Wilkins C
Drug Test Anal; 2016 Aug; 8(8):768-78. PubMed ID: 26857892
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
Gray R; Bressington D; Hughes E; Ivanecka A
J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
[TBL] [Abstract][Full Text] [Related]
5. A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill)health. Legal highs or illegal highs?
Ayres TC; Bond JW
BMJ Open; 2012; 2(4):. PubMed ID: 22855623
[TBL] [Abstract][Full Text] [Related]
6. The dilemma of new psychoactive substances: A growing threat.
Sajwani HS
Saudi Pharm J; 2023 Mar; 31(3):348-350. PubMed ID: 37026049
[TBL] [Abstract][Full Text] [Related]
7. Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, 'legal highs') in New Zealand.
Rychert M; Wilkins C
Int J Drug Policy; 2016 Nov; 37():90-97. PubMed ID: 27639994
[TBL] [Abstract][Full Text] [Related]
8. The challenge of a ban on animal testing for the development of a regulated legal market for new psychoactive substances (NPS) ('legal highs') in New Zealand: Issues and options for resolution.
Rychert M; Wilkins C
Int J Drug Policy; 2015 Dec; 26(12):1273-8. PubMed ID: 26364077
[TBL] [Abstract][Full Text] [Related]
9. "Legal highs" - new players in the old drama.
Zawilska JB
Curr Drug Abuse Rev; 2011 Jun; 4(2):122-30. PubMed ID: 21711229
[TBL] [Abstract][Full Text] [Related]
10. Phencyclidine analog use in Sweden--intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project.
Bäckberg M; Beck O; Helander A
Clin Toxicol (Phila); 2015 Nov; 53(9):856-64. PubMed ID: 26295489
[TBL] [Abstract][Full Text] [Related]
11. 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances.
Wallach J; Brandt SD
Handb Exp Pharmacol; 2018; 252():305-352. PubMed ID: 30196446
[TBL] [Abstract][Full Text] [Related]
12. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
13. The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review.
Orsolini L; Chiappini S; Corkery JM; Guirguis A; Papanti D; Schifano F
Expert Rev Neurother; 2019 Dec; 19(12):1253-1264. PubMed ID: 31503507
[No Abstract] [Full Text] [Related]
14. Next generation of novel psychoactive substances on the horizon - A complex problem to face.
Zawilska JB; Andrzejczak D
Drug Alcohol Depend; 2015 Dec; 157():1-17. PubMed ID: 26482089
[TBL] [Abstract][Full Text] [Related]
15. Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances ('legal highs') in New Zealand.
Rychert M; Wilkins C; Witten K
Drug Alcohol Rev; 2017 Sep; 36(5):589-596. PubMed ID: 28229493
[TBL] [Abstract][Full Text] [Related]
16. The e-Psychonauts' 'Spiced' World; Assessment of the Synthetic Cannabinoids' Information Available Online.
Zangani C; Schifano F; Napoletano F; Arillotta D; Gilgar L; Guirguis A; Corkery JM; Gambini O; Vento A
Curr Neuropharmacol; 2020; 18(10):966-1051. PubMed ID: 32116194
[TBL] [Abstract][Full Text] [Related]
17. New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic.
Lo Faro AF; Berardinelli D; Cassano T; Dendramis G; Montanari E; Montana A; Berretta P; Zaami S; Busardò FP; Huestis MA
Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829550
[TBL] [Abstract][Full Text] [Related]
18. 'Legal highs'--novel and emerging psychoactive drugs: a chemical overview for the toxicologist.
Gibbons S
Clin Toxicol (Phila); 2012 Jan; 50(1):15-24. PubMed ID: 22248120
[TBL] [Abstract][Full Text] [Related]
19. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
Napoletano S; Basile G; Lo Faro AF; Negro F
Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
[TBL] [Abstract][Full Text] [Related]
20. Syntheses, analytical and pharmacological characterizations of the 'legal high' 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine (3-MeO-PCMo) and analogues.
Colestock T; Wallach J; Mansi M; Filemban N; Morris H; Elliott SP; Westphal F; Brandt SD; Adejare A
Drug Test Anal; 2018 Feb; 10(2):272-283. PubMed ID: 28513099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
